Truist Financial (TFC) FY2025 10-K Annual Report
Truist Financial (TFC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 24, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Truist Financial FY2025 10-K Analysis
Business Overview
- • Top-10 U.S. commercial bank operating 1,927 branches across Southeast, Mid-Atlantic, and select other states with two segments: Wholesale Banking (WB) and CSBB
- • 2025 strategy emphasized commercial middle market via industry banking, Investment Banking momentum, and Premier client deposit growth in CSBB
Management Discussion & Analysis
- • Revenue (NII + noninterest income) not explicitly broken out as a single total; NII rose to $12.3B in 2025 vs $11.4B in 2024, up ~8% YoY driven by deposit repricing and loan growth
- • Net income available to common shareholders $5.1B in 2025 vs $4.3B in 2024; operating efficiency ratio 56.1% vs 59.2% prior year
Risk Factors
- • Regulatory capital rules under Basel Framework/Dodd-Frank and Category III BHC status impose more stringent LCR, NSFR, and stress capital buffer requirements than smaller rivals
- • Geopolitical instability and U.S. tariff/trade policy uncertainty threaten commercial lending conditions, collateral values, and client creditworthiness across Truist's Southeast-heavy footprint
Truist Financial FY2025 Key Financial MetricsXBRL
Revenue
$24.5B
▼ -2.1% YoY
Net Income
$5.0B
▲ +11.3% YoY
Net Margin
20.3%
▲ +244bp YoY
ROE
7.6%
▲ +61bp YoY
Total Assets
$547.5B
▲ +3.1% YoY
EPS (Diluted)
$3.82
▲ +13.7% YoY
Operating Cash Flow
$5.7B
▲ +165.2% YoY
Source: XBRL data from Truist Financial FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Truist Financial Annual Reports
Get deeper insights on Truist Financial
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.